PT - JOURNAL ARTICLE AU - Aryan Gulati TI - LungAI: A Deep Learning Convolutional Neural Network for Automated Detection of COVID-19 from Posteroanterior Chest X-Rays AID - 10.1101/2020.12.19.20248530 DP - 2020 Jan 01 TA - medRxiv PG - 2020.12.19.20248530 4099 - http://medrxiv.org/content/early/2020/12/23/2020.12.19.20248530.short 4100 - http://medrxiv.org/content/early/2020/12/23/2020.12.19.20248530.full AB - COVID-19 is an infectious disease caused by the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2). As of December 2020, more than 72 million cases have been reported worldwide. The standard method of diagnosis is by Real-Time Reverse Transcription Polymerase Chain Reaction (rRT-PCR) from a Nasopharyngeal Swab. Currently, there is no vaccine or specific antiviral treatment for COVID-19. Due to rate of spreading of the disease manual detection among people is becoming more difficult because of a clear lack of testing capability. Thus there was need of a quick and reliable yet non-labour intensive detection technique. Considering that the virus predominantly appears in the form of a lung based abnormality I made use of Chest X-Rays as our primary mode of detection. For this detection system we made use of Posteroanterior (PA) Chest X-rays of people infected with Bacterial Pneumonia (2780 Images), Viral Pneumonia (1493 Images), Covid-19 (729 Images) as well as those of perfectly Healthy Individuals (1583 Images) procured from various Publicly Available Datasets and Radiological Societies. LungAI is a novel Convolutional Neural Network based on a Hybrid of the DarkNet and AlexNet architecture. The network was trained on 80% of the dataset with 20% kept for validation. The proposed Coronavirus Detection Model performed exceedingly well with an accuracy of 99.16%, along with a Sensitivity value of 99.31% and Specificity value of 99.14%. Thus LungAI has the potential to prove useful in managing the current Pandemic Situation by providing a reliable and fast alternative to Coronavirus Detection given strong results.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis study did not receive external funding.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:No IRB.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).Yes I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesThe datasets analyzed during the current study are available in various public and open repositories. https://github.com/ieee8023/covid-chestxray-dataset https://www.sirm.org/en/category/articles/covid-19-database/ https://www.kaggle.com/paultimothymooney/chest-xray-pneumonia